$ABIO News After-hours trades still risky, a d
Post# of 89397
Posted On: 12/11/2014 12:40:35 PM
$ABIO News
After-hours trades still risky, a decade later 2:23 p.m. June 9, 2011 - Kate Gibson
Monday's biggest gaining and declining stocks 3:20 p.m. May 17, 2010 - MarketWatch
MDRNA, ARCA move on patent office updates 1:08 p.m. March 29, 2010 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:36 p.m. March 26, 2010 - MarketWatch
ARCA Bio surges 226% on patent 2:22 p.m. March 26, 2010 - Shawn Langlois
ARCA Biopharma shares surge 220% to $8.56 2:02 p.m. March 26, 2010 - Laura Mandaro
Monday's biggest gaining and declining stocks 3:43 p.m. June 1, 2009 - MarketWatch
Arca continues Orphan Drug-stoked up move 11:21 a.m. Today - Seeking Alpha
Arca TF inhibitor an Orphan Drug for hemorrhagic fever 10:14 a.m. Dec. 10, 2014 - Seeking Alpha
ARCA's CFO leaving; COO appointed 6:11 p.m. Dec. 1, 2014 - Seeking Alpha
10-Q: ARCA BIOPHARMA, INC. 5:16 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: ARCA BIOPHARMA, INC. 7:14 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
ARCA Biopharma: An Undervalued Biotech With A Bright Future 9:50 a.m. July 3, 2014 - Seeking Alpha
Checking In On ARCA Biopharma 7:50 a.m. March 25, 2014 - Seeking Alpha
10-K: ARCA BIOPHARMA, INC. 4:00 p.m. March 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notes From One-On-One Meetings During San Fran Biotech Week - Day 2 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Why Arca Biopharma Is A Buy 2:50 p.m. Jan. 14, 2014 - Seeking Alpha
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients 3:53 p.m. Jan. 10, 2014 - Seeking Alpha
FDA accepts test to be used in ARCA Biopharma trial 9:16 a.m. Jan. 8, 2014 - Seeking Alpha
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial 10:10 a.m. Dec. 4, 2013 - Seeking Alpha
OCLS – Why Oculus Jumped Over 145% Today 8:27 a.m. Dec. 4, 2013 - InvestorPlace.com
10-Q: ARCA BIOPHARMA, INC. 4:41 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Refined And Ready To Rebound: We Like What We See At Arca Bio 8:00 a.m. Sept. 9, 2013 - Seeking Alpha
Arca Biopharma Prepares For A Second Life 4:52 p.m. Aug. 21, 2013 - Seeking Alpha
10-Q: ARCA BIOPHARMA, INC. 4:25 p.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Close: Big Winners & Losers for April 23, 2013 2:51 p.m. April 23, 2013 - 247WallSt.com
Biogen Idec, Celgene And AbbVie Move To New Highs 4:24 p.m. April 22, 2013 - Investors Business Daily
Arca biopharma Announces Activation of First Canadian Genetic-AF Clinical Trial Site 8:58 a.m. Today - BusinessWire - BZX
ARCA biopharma Receives FDA Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola 8:31 a.m. Dec. 10, 2014 - BusinessWire - BZX
ARCA biopharma Announces Management Transitions 5:00 p.m. Dec. 1, 2014 - BusinessWire - BZX
LabCorp/ARCA biopharma GENETIC-AF Poster Presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America 7:03 a.m. Sept. 16, 2014 - BusinessWire - BZX
LabCorp/ARCA biopharma GENETIC-AF Poster Selected for Presentation at the 18th Annual Scientific Meeting of the Heart Failure Society of America 7:31 a.m. Sept. 8, 2014 - BusinessWire - BZX
ARCA biopharma Announces Health Canada Acceptance of Genetic-AF Clinical Trial Application 7:31 a.m. Aug. 18, 2014 - BusinessWire - BZX
Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors 7:31 a.m. June 9, 2014 - BusinessWire - BZX
ARCA biopharma to Present at the Growth Capital Expo 2014 8:02 a.m. April 22, 2014 - BusinessWire - BZX
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation 7:31 a.m. April 17, 2014 - BusinessWire - BZX
ARCA biopharma Files Shelf Registration Statement 3:06 p.m. April 4, 2014 - BusinessWire - BZX
ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio 6:05 a.m. March 19, 2014 - Marketwire
Top Gainers Technical Data: Ocean Power Technologies, ARCA Biopharma, Ubiquiti Networks, and Pinnacle Entertainment 8:24 a.m. March 12, 2014 - PR Newswire - PRF
Dan Mitchell Joins ARCA biopharma Board of Directors 9:16 a.m. Feb. 12, 2014 - BusinessWire - BZX
ARCA biopharma Announces Pricing of $9 Million Public Offering of Common Stock and Warrants 8:31 a.m. Feb. 4, 2014 - BusinessWire - BZX
ARCA biopharma Announces Proposed Public Offering of Common Stock and Warrants 4:06 p.m. Feb. 3, 2014 - BusinessWire - BZX
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
ARCA biopharma Announces US FDA Acceptance of Gencaro Companion Diagnostic Test IDE 8:30 a.m. Jan. 8, 2014 - BusinessWire
ARCA biopharma to Present at Biotech Showcase 2014 8:30 a.m. Jan. 7, 2014 - BusinessWire
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma 9:18 a.m. Dec. 5, 2013 - PR Newswire
After-hours trades still risky, a decade later 2:23 p.m. June 9, 2011 - Kate Gibson
Monday's biggest gaining and declining stocks 3:20 p.m. May 17, 2010 - MarketWatch
MDRNA, ARCA move on patent office updates 1:08 p.m. March 29, 2010 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:36 p.m. March 26, 2010 - MarketWatch
ARCA Bio surges 226% on patent 2:22 p.m. March 26, 2010 - Shawn Langlois
ARCA Biopharma shares surge 220% to $8.56 2:02 p.m. March 26, 2010 - Laura Mandaro
Monday's biggest gaining and declining stocks 3:43 p.m. June 1, 2009 - MarketWatch
Arca continues Orphan Drug-stoked up move 11:21 a.m. Today - Seeking Alpha
Arca TF inhibitor an Orphan Drug for hemorrhagic fever 10:14 a.m. Dec. 10, 2014 - Seeking Alpha
ARCA's CFO leaving; COO appointed 6:11 p.m. Dec. 1, 2014 - Seeking Alpha
10-Q: ARCA BIOPHARMA, INC. 5:16 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: ARCA BIOPHARMA, INC. 7:14 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
ARCA Biopharma: An Undervalued Biotech With A Bright Future 9:50 a.m. July 3, 2014 - Seeking Alpha
Checking In On ARCA Biopharma 7:50 a.m. March 25, 2014 - Seeking Alpha
10-K: ARCA BIOPHARMA, INC. 4:00 p.m. March 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notes From One-On-One Meetings During San Fran Biotech Week - Day 2 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Why Arca Biopharma Is A Buy 2:50 p.m. Jan. 14, 2014 - Seeking Alpha
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients 3:53 p.m. Jan. 10, 2014 - Seeking Alpha
FDA accepts test to be used in ARCA Biopharma trial 9:16 a.m. Jan. 8, 2014 - Seeking Alpha
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial 10:10 a.m. Dec. 4, 2013 - Seeking Alpha
OCLS – Why Oculus Jumped Over 145% Today 8:27 a.m. Dec. 4, 2013 - InvestorPlace.com
10-Q: ARCA BIOPHARMA, INC. 4:41 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Refined And Ready To Rebound: We Like What We See At Arca Bio 8:00 a.m. Sept. 9, 2013 - Seeking Alpha
Arca Biopharma Prepares For A Second Life 4:52 p.m. Aug. 21, 2013 - Seeking Alpha
10-Q: ARCA BIOPHARMA, INC. 4:25 p.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Close: Big Winners & Losers for April 23, 2013 2:51 p.m. April 23, 2013 - 247WallSt.com
Biogen Idec, Celgene And AbbVie Move To New Highs 4:24 p.m. April 22, 2013 - Investors Business Daily
Arca biopharma Announces Activation of First Canadian Genetic-AF Clinical Trial Site 8:58 a.m. Today - BusinessWire - BZX
ARCA biopharma Receives FDA Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola 8:31 a.m. Dec. 10, 2014 - BusinessWire - BZX
ARCA biopharma Announces Management Transitions 5:00 p.m. Dec. 1, 2014 - BusinessWire - BZX
LabCorp/ARCA biopharma GENETIC-AF Poster Presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America 7:03 a.m. Sept. 16, 2014 - BusinessWire - BZX
LabCorp/ARCA biopharma GENETIC-AF Poster Selected for Presentation at the 18th Annual Scientific Meeting of the Heart Failure Society of America 7:31 a.m. Sept. 8, 2014 - BusinessWire - BZX
ARCA biopharma Announces Health Canada Acceptance of Genetic-AF Clinical Trial Application 7:31 a.m. Aug. 18, 2014 - BusinessWire - BZX
Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors 7:31 a.m. June 9, 2014 - BusinessWire - BZX
ARCA biopharma to Present at the Growth Capital Expo 2014 8:02 a.m. April 22, 2014 - BusinessWire - BZX
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation 7:31 a.m. April 17, 2014 - BusinessWire - BZX
ARCA biopharma Files Shelf Registration Statement 3:06 p.m. April 4, 2014 - BusinessWire - BZX
ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio 6:05 a.m. March 19, 2014 - Marketwire
Top Gainers Technical Data: Ocean Power Technologies, ARCA Biopharma, Ubiquiti Networks, and Pinnacle Entertainment 8:24 a.m. March 12, 2014 - PR Newswire - PRF
Dan Mitchell Joins ARCA biopharma Board of Directors 9:16 a.m. Feb. 12, 2014 - BusinessWire - BZX
ARCA biopharma Announces Pricing of $9 Million Public Offering of Common Stock and Warrants 8:31 a.m. Feb. 4, 2014 - BusinessWire - BZX
ARCA biopharma Announces Proposed Public Offering of Common Stock and Warrants 4:06 p.m. Feb. 3, 2014 - BusinessWire - BZX
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
ARCA biopharma Announces US FDA Acceptance of Gencaro Companion Diagnostic Test IDE 8:30 a.m. Jan. 8, 2014 - BusinessWire
ARCA biopharma to Present at Biotech Showcase 2014 8:30 a.m. Jan. 7, 2014 - BusinessWire
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma 9:18 a.m. Dec. 5, 2013 - PR Newswire
(0)
(0)